Garg, S.K.; Sun, J.; Kim, Y.; Whiting, J.; Sarnaik, A.; Conejo-Garcia, J.R.; Phelps, M.; Weber, J.S.; Mulé, J.J.; Markowitz, J.
Dichotomous Nitric Oxide–Dependent Post-Translational Modifications of STAT1 Are Associated with Ipilimumab Benefits in Melanoma. Cancers 2023, 15, 1755.
https://doi.org/10.3390/cancers15061755
AMA Style
Garg SK, Sun J, Kim Y, Whiting J, Sarnaik A, Conejo-Garcia JR, Phelps M, Weber JS, Mulé JJ, Markowitz J.
Dichotomous Nitric Oxide–Dependent Post-Translational Modifications of STAT1 Are Associated with Ipilimumab Benefits in Melanoma. Cancers. 2023; 15(6):1755.
https://doi.org/10.3390/cancers15061755
Chicago/Turabian Style
Garg, Saurabh K., James Sun, Youngchul Kim, Junmin Whiting, Amod Sarnaik, José R. Conejo-Garcia, Mitch Phelps, Jeffrey S. Weber, James J. Mulé, and Joseph Markowitz.
2023. "Dichotomous Nitric Oxide–Dependent Post-Translational Modifications of STAT1 Are Associated with Ipilimumab Benefits in Melanoma" Cancers 15, no. 6: 1755.
https://doi.org/10.3390/cancers15061755
APA Style
Garg, S. K., Sun, J., Kim, Y., Whiting, J., Sarnaik, A., Conejo-Garcia, J. R., Phelps, M., Weber, J. S., Mulé, J. J., & Markowitz, J.
(2023). Dichotomous Nitric Oxide–Dependent Post-Translational Modifications of STAT1 Are Associated with Ipilimumab Benefits in Melanoma. Cancers, 15(6), 1755.
https://doi.org/10.3390/cancers15061755
